Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic

American Journal of Tropical Medicine and Hygiene

Volumn 74, Issue 2, 2006, Pages 205-210

  Menard, Didier ^a,b   Djalle, Djibrine ^a   Yapou, Ferdinand ^a   Manirakiza, Alexandre ^a   Talarmin, Antoine ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; MULTIDRUG RESISTANCE PROTEIN 1; GLYCOPROTEIN P; MEMBRANE PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ALLELE; ARTICLE; BLOOD SAMPLING; CODON; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; ANIMAL; CENTRAL AFRICAN REPUBLIC; DRUG COMBINATION; DRUG EFFECT; GENETICS; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; MUTATION;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; CENTRAL AFRICAN REPUBLIC; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; GENE FREQUENCY; HUMANS; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MUTATION; P-GLYCOPROTEIN; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE;

EID: 33645829827     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.74.205     Document Type: Article

References (40)

1. WHO/CDS/MAL, 2003. 2003 Africa Malaria Report. Geneva: World Health Organization.
2. Pierce PF, Milhous WK, Campbell CC, 1987. Clinical and laboratory characterization of a chloroquine-resistant Plasmodium falciparum strain acquired in the Central African Republic. Am J Trop Med Hyg 36: 1-2.
3. Belec L, Delmont J, Vesters I, Testa J, Christian KS, Georges AJ, 1988. Emergence of multiresistant Plasmodium falciparum malaria in the Central African Republic. Presse Med 17: 2090-2091.
4. Menard D, Manirakiza A, Djalle D, Koula MR, Talarmin A, 2005. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine- pyrimethamine combination and amodiaquine-sulfadoxine-pyrimethamine combination in central African children with non-complicated malaria. Am J Trop Med Hyg 72: 581-585.
5. Menard D, Yapou F, Siadoua V, Sana S, Matsika-Claquin MD, Madji N, Talarmin A, 2005. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment. Am J Trop Med Hyg 73: 239-243.
6. Wellems TE, Plowe CV, 2001. Chloroquine-resistant malaria. J Infect Dis 184: 770-776.
7. Cowman AF, 1998. The molecular basis of resistance to the sulfone, sulfonamides, and dihydrofolate reductase inhibitors. Sherman IW, ed. Malaria Parasite Biology, Pathogenesis, and Protection. Washington, DC: American Society for Microbiology Press, 317-330..
8. Basco LK, Ringwald P, 1997. pfmdr1 gene mutation and clinical response to chloroquine in Yaounde, Cameroon. Trans R Soc Trop Med Hyg 91: 210-211.
9. Curtis J, Duraisingh MT, Warhurst DC, 1998. In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment. J Infect Dis 177: 1429-1433.
10. Gomez-Saladin E, Fryauff DJ, Taylor WR, Laksana BS, Susanti AI, Purnomo , Subianto B, Richie TL, 1999. Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia. Am J Trop Med Hyg 61: 240-244.
11. Jelinek T, Kilian AH, Kabagambe G, von Sonnenburg F, 1999. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes. Am J Trop Med Hyg 61: 463-466.
12. Basco LK, Tahar R, Ringwald P, 1998. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrob Agents Chemother 42: 1811-1814.
13. Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM, 2000. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother 44: 991-996.
14. Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Bjorkman A, Kobayakawa T, 2003. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop 85: 363-373.
15. Wang P, Read M, Sims PF, Hyde JE, 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 23: 979-986.
16. Nagesha HS, Din S, Casey GJ, Susanti AI, Fryauff DJ, Reeder JC, Cowman AF, 2001. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in vivo drug resistance in West Papua, Indonesia. Trans R Soc Trop Med Hyg 95: 43-49.
17. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
18. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 257-263.
19. UNICEF, 2001. Enquête à Indicateurs Multiples, MICS 2000. Editions B, ed. Rapport Final Bangui. Bangui: Ministère du Plan, RCA, 130-131.
20. Basco LK, Ndounga M, Tejiokem M, Ngane VF, Youmba JC, Ringwald P, Soula G, 2002. Molecular epidemiology of malaria in Cameroon. XI. Geographic distribution of Plasmodium falciparum isolates with dihydrofolate reductase gene mutations in southern and central Cameroon. Am J Trop Med Hyg 67: 378-382.
21. Ranford-Cartwright LC, Johnston KL, Abdel-Muhsin AM, Khan BK, Babiker HA, 2002. Critical comparison of molecular genotyping methods for detection of drug-resistant Plasmodium falciparum. Trans R Soc Trop Med Hyg 96: 568-572.
22. Basco LK, 2002. Molecular epidemiology of malaria in Cameroon. XIII. Analysis of pfcrt mutations and in vitro chloroquine resistance. Am J Trop Med Hyg 67: 388-391.
23. Binder RK, Borrmann S, Adegnika AA, Missinou MA, Kremsner PG, Kun JF, 2002. Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambaréné, Gabon. Parasitol Res 88: 475-476.
24. Wilson PE, Kazadi W, Kamwendo DD, Mwapasa V, Purfield A, Meshnick SR, 2005. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop 93: 97-106.
25. Anderson TJ, Nair S, Jacobzone C, Zavai A, Balkan S, 2003. Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan. Trop Med Int Health 8: 1068-1073.
26. Happi TC, Thomas SM, Gbotosho GO, Falade CO, Akinboye DO, Gerena L, Hudson T, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM, 2003. Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann Trop Med Parasitol 97: 439-451.
27. Thomas SM, Ndir O, Dieng T, Mboup S, Wypij D, Maguire JH, Wirth DF. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg 66: 74-80
28. Kyosiimire-Lugemwa J, Nalunkuma-Kazibwe AJ, Mujuzi G, Mulindwa H, Talisuna A, Egwang TG, 2002. The Lys-76-Thr mutation in PfCRT and chloroquine resistance in Plasmodium falciparum isolates from Uganda. Trans R Soc Trop Med 96: 91-95.
29. Jelinek T, Aida AO, Peyerl-Hoffmann G, Jordan S, Mayor A, Heuschkel C, el Valy AO, von Sonnenburg F, Christophel EM, 2002. Diagnostic value of molecular markers in chloroquineresistant falciparum malaria in southern Mauritania. Am J Trop Med Hyg. 67: 449-453.
30. Tinto H, Ouedraogo JB, Erhart A, Van Overmeir C, Dujardin JC, Van Marck E, Guiguemde TR, D'Alessandro U, 2003. Relationship between the pfcrt T76 and the pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, west Africa. Infect Genet Evol 3: 287-292.
31. Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M, Greenwood BM, Pinder M, Warhurst D, Targett GA, 2002. Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg 67: 578-585.
32. Grobusch MP, Adagu IS, Kremsner PG, Warhurst DC, 1998. Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon. Parasitology 116: 211-217.
33. Flueck TP, Jelinek T, Kilian AH, Adagu IS, Kabagambe G, Sonnenburg F, Warhurst DC, 2000. Correlation of in vivo resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda. Trop Med Int Health 5: 174-178.
34. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, 1990. Several alleles of the multidrugresistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
35. Zalis MG, Pang L, Silveira MS, Milhous WK, Wirth DF, 1998. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg 58: 630-637.
36. Aubouy A, Jafari S, Huart V, Migot-Nabias F, Mayombo J, Durand R, Bakary M, Le Bras J, Deloron P, 2003. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 52: 43-49.
37. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 185: 380-388.
38. Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Ronn AM, 2003. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity. Am J Trop Med Hyg 69: 601-606.
39. Hima-Lerible H, Menard D, Talarmin A, 2003. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic. J Antimicrob Chemother 51: 192-194.
40. Matsika-Claquin MD, Massanga M, Menard D, Mazi-Nzapako J, Tenegbia JP, Mandeng MJ, Willybiro-Sacko J, Fontanet A, Talarmin A, 2004. HIV epidemic in Central African Republic: high prevalence rates in both rural and urban areas. J Med Virol 72: 358-362.